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ABSTRACT
Background: Clinical epidemiology data for young adults on
renal replacement therapy (RRT) are lacking. While mostly
transplanted, they have an increased risk of graft loss during
young adulthood.
Methods: We combined the UK Renal Registry paediatric and
adult databases to describe patient characteristics, transplanta-
tion and survival for young adults. We grouped patients 11–30
years of age starting RRT from 1999 to 2008 by age band and
examined their course during 5 years of follow-up.
Results: The cohort (n¼ 3370) was 58% male, 79% white and
29% had glomerulonephritis. Half (52%) started RRT on hae-
modialysis (HD). Most (78%) were transplanted (18% pre-
emptive, 61% as second modality); 11% were not listed for
transplant. Transplant timing varied by age group. The decea-
sed:living donor kidney transplant ratio was 2:1 for 11–<16
year olds and 1:1 otherwise. Median deceased donor transplant
waiting times ranged from 6 months if <16 years of age to 17
months if 21 years. Overall 8% died, with being on dialysis
and not transplant listed versus transplanted fhazard ratio
[HR] 17.6 [95% conﬁdence interval (CI) 4.36–70.9],
P< 0.0001g and diabetes versus glomerulonephritis [HR 4.48
(95% CI 3.05–6.58), P< 0.0001] increasing mortality risk.
Conclusions: This study highlights the frequent use of HD and
the importance of transplant listing and diabetes for young
adults. More than half the young adults in our cohort started
renal replacement therapy on HD. One in 10 young adults were
not listed for transplant by 5 years and were 20 times more
likely to die than those who were transplanted. Diabetes as a pri-
mary renal disease was common among young adults and asso-
ciated with increased mortality. Overall, almost 1 in 10 young
adults had died by 5 years from the start of RRT.
Keywords: clinical epidemiology, dialysis, kidney transplanta-
tion, registries, survival, young adult
INTRODUCTION
Comprehensive data focusing on young adults on renal replace-
ment therapy (RRT) are lacking. The majority are managed
with a kidney transplant; the latest UK data show 91.8% of prev-
alent 16–18 year olds in paediatric services and 72.9% of preva-
lent 18–24 year olds in adult services were transplant patients
[1, 2]. Most children in the UK receiving RRT have a renal
transplant [1], and those listed when <18 years of age receive
greater priority on the national deceased donor transplant wait-
ing list [3–5]. Although transplantation is seen as the treatment
of choice, international data demonstrate a higher risk of graft
loss during young adulthood [6], with those who are trans-
planted in childhood and transfer to adult services frequently
studied [7, 8]. In a single-centre UK study, 8 of 20 kidney trans-
plants in 18 year olds unexpectedly failed inside 3 years of trans-
fer from paediatric to adult services [9]. Young adulthood is a
time of increasing independence, experimentation and respon-
sibility, when the brain and complex decision-making abilities
are still maturing [10]. Clarity on management practices for
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|young adults on RRT in the UK is necessary for improvements
in the survival of these grafts, assuming that some of these losses
are due to modifiable factors.
The UK Renal Registry (UKRR) reports on all established
RRT patients. The first UKRR annual report was published in
1998 [11], with complete electronic coverage of adult units from
2008 [12]. Paediatric data were first reported in 1999 with com-
plete coverage [13]. We aimed to describe the clinical epidemi-
ology of young adults on RRT in the UK to determine changing
characteristics between childhood and adulthood by combining
paediatric and adult databases in order to capture all patients.
We were specifically interested in transplantation practices for
this group and wanted to identify high-risk groups with poor
survival, providing potential targets for further service
development.
MATERIALS AND METHODS
We created a dataset of young patients starting RRT over a 10-
year period between 1999 and 2008 using UKRR data. This
required extracting and merging data from separate adult and
paediatric databases. We included all patients 11 years of age
from the paediatric database and patients registered in adult
renal centres reporting to the UKRR at the time of RRT start
from the adult database (see Figure 1). We chose broad age cut-
offs of 11 and 30 years because there is no clear consensus as to
what age groups constitute young adulthood and we wanted
overlap with paediatric and adult groups to see if any
age-related trends were continuous across the age range. We
divided the cohort into four bands according to age at RRT
start; 11–<16, 16–<21, 21–<26 and 26–30 years. We examined
5 years of longitudinal data for each subject, so an individual
starting RRT in 2008 had follow-up to the most recent registry
data return on 31 December 2013, using 15 years of UKRR data
(1999–2013).
Where data were discordant between the databases, we
selected the paediatric data, which tended to offer more detail.
NHS Blood and Transplant provided missing ethnicity and
transplant listing data. Queries were resolved with individual
case review; Supplementary Table S1 details these.
Beginning with clinical characteristics, we examined sex, age,
ethnicity and primary renal diagnosis (PRD), grouped using the
2012 ERA-EDTA coding [14]. We added subgroups in order to
identify conditions of particular interest. We did not analyse
demographics by time period due to incomplete UKRR cover-
age during the study period. We calculated a 2008 RRT inci-
dence using Office for National Statistics (ONS) UK census data
to obtain age-specific denominators [15].
For management, we investigated RRT start modality and
pre-emptive transplantation, modality changes, transplant list-
ing, first transplant type and time to transplant from listing
for deceased donor grafts. In keeping with UKRR reports, we
assumed that patients with a live transplant who either did
not have a transplant listing date or had a date within 6
months of their transplant were listed for transplantation 6
months before their live transplant date, and modality
changes between haemodialysis (HD) and peritoneal dialysis
(PD) were defined as those lasting>90 days. We analysed
graft loss by including all first and second transplants with 1
year of follow-up data and defining loss as return to dialysis,
elective retransplantation or death. We assumed those lost to
FIGURE 1: Flowchart showing how the cohort was constructed from the UK RR databases. At RRT start, patients were present in one database.
During follow-up, data for paediatric patients moved to the adult database if they transferred to adult services. There were no data queries from
the adult database. Further details around missing and discordant data are available in Supplementary Table S1. UKRR, UK Renal Registry;
RRT, renal replacement therapy.
2 A.J. Hamilton et al.
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|of follow-up had a functioning graft at 1 year. We also
recorded starting unit type (paediatric or adult) and details of
transfer to adult services where applicable.
Statistical analysis compared characteristics between patients
in different age groups using tests appropriate to their data and
distribution. We compared continuous data using the Kruskal–
Wallis test for medians and the chi-square test for categorical
variables.
For survival, we calculated crude and relative mortality rates
per 1000 patient-years, comparing these with the 2001–14
(equivalent time period) average age-matched general popula-
tion mortality data from the ONS [15]. We determined 95%
confidence intervals (CIs) using Poisson regression. We looked
at survival by age group using Kaplan–Meier plots and with a
relative survival analysis [16], also using ONS data. A relative
survival analysis adjusts the observed survival in the specific
cohort for the background mortality risk seen in the general
population so that the initial cumulative observed survival is
converted to a cumulative relative survival. Hence, if worse sur-
vival observed in older compared with younger renal patients
was a function of higher risk of dying in the general population,
the relative survival would be more similar between the two
groups than the observed survival. By using a multivariable Cox
regression model, we explored the influence of age group
adjusted by possible confounder variables in addition to age
group on the risk of death after RRT start [hazard ratio (HR)
(95% CI), P-value], having tested for the assumption of propor-
tionality using visual plots, Schoenfeld residuals and testing for
a log–time interaction. All subjects who remained alive after 5
years were censored at that time point. Censoring was also
applied at recovery of renal function or if lost to follow-up. We
analysed modality (transplant versus ‘dialysis, transplant listed’
and ‘dialysis, not transplant listed’) as a time-dependent varia-
ble, as this can change over the follow-up period. Each patient
contributed to the survivor function of the treatment groups for
the relevant time depending on the patient treatment timeline,
and we attributed deaths to the current modality, with no cross-
over for the transplant to dialysis switch. As this analysis could
not be adjusted for referral time due to missing data, a sensitiv-
ity analysis of survival after 90 days from RRT start was also
performed, to remove any confounding effects of starting dialy-
sis within 90 days of the first nephrology review. As some indi-
cation of non-proportionality was observed for diabetics versus
non-diabetic patients, we also performed piecewise Cox regres-
sion stratifying by diabetic status.
RESULTS
The patient frequency, ethnic group and PRD group propor-
tions by age group are displayed in Figures 2–4, respectively,
with data including gender and PRD subgroups available in
Supplementary Table S2. Overall data completeness was high.
As shown in Supplementary Table S2, there was 1.0% missing
ethnic data and only 0.7% of ethnic codes were discordant in
patients registered in both paediatric and adult databases. There
were similar missing data for PRD, with 1.9% missing and 1.3%
discordant. We were able to link all but 15 patients (2.6%) who
transferred from paediatric to adult services between the paedi-
atric and adult databases, showing the ability to track patients
longitudinally.
Clinical epidemiology
Figure 2 demonstrates increasing absolute patient numbers
in the cohort with older age group. The UK 2008 incidence of
RRT by age group at RRT start increased with age; the rate was
16.3 per million age-related population for the 11–<16 group,
20.0 for the 16–<21 group, 27.7 for the 21–<26 group and 46.1
for the 26–30 group. Young adults starting RRT in the UK were
predominantly male (57.9%), with no difference in gender by
age group.
Figure 3 shows that the majority were of White ethnicity
(78.5% overall), with variation in ethnic group proportions by
age group (P< 0.05).
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FIGURE 2: Patient frequency by age group in incident UK young adult RRT patients between 1999 and 2008. Percentages are shown for each
group.
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Figure 4 shows a decrease in tubulointerstitial and inherited
PRDs and an increase in systemic diseases and miscellaneous
conditions with increasing age group (P< 0.0001). As shown in
Supplementary Table S2, there was a striking increase by age in
diabetes causing end-stage renal disease (ESRD), with 17.4% of
PRDs in the 26–30-year age group accounted for by diabetes.
Management
Start modality. Figures 5 and 6 show that half of young
adults started RRT on HD, with more pre-emptive transplanta-
tion in the youngest age group. Overall, 51.8% received HD,
30.2% PD and 14.1% started RRT with a transplant, with strong
statistical evidence of a difference in the RRT start modality by
age group (P< 0.0001). Data regarding late referral were avail-
able for half the cohort and showed 29% had started dialysis
within 90 days of the first nephrology review.
Modality changes over the first 5 years of RRT. Figure 6
demonstrates transplantation was the major treatment for
young adults, increasing rapidly in the first 3 years. HD was the
next most frequently used modality, with PD least used.
Table 1 shows more detail about the use of transplantation
in the first 5 years of RRT. Overall, 78.0% received a transplant
within the first 5 years of starting RRT, with a higher proportion
(93.0%) of the youngest patients receiving a transplant com-
pared with the oldest (72.2%) (P< 0.0001). Of those trans-
planted, 18.1% were pre-emptive and 62.5% received a
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FIGURE 3: Ethnic group by age group in incident UK young adult RRT patients between 1999 and 2008. Percentages are shown for each
group. P< 0.05, chi-square test.
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FIGURE 4: PRD groups by age group in incident young adult RRT patients between 1999 and 2008. Percentages are shown for each group.
P< 0.0001, chi-square test. Percentages are shown for each group. PRD is grouped using the 2012 ERA-EDTA coding [12]; ‘Tubulointerstitial
disease’ includes structural renal disorders. Subgroup data are available in Supplementary Table S2.
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|transplant after one dialysis modality. In terms of first trans-
plant type, the proportion of living donor transplants increased
with age (P< 0.0001), with a decreasing use of deceased donor
transplants with increasing age, though this was non-linear, so
the biggest change was seen between the 11–<16 and 16–<21
age groups. The overall median time to receiving a deceased
donor transplant from listing was 13 months, and increased
with age group (P< 0.0001). The difference in waiting time
between the youngest and oldest groups was 1.67 times longer,
or 11 months, reflecting preferential deceased donor allocation
to younger patients. During the study period, 2522 of the 2696
(93.5%) grafts remained functioning at 1 year, with no differ-
ence by age group. These results demonstrate that in young
adult patients starting RRT, transplantation occurs early and, in
the majority, using a roughly equal proportion of living and
deceased donors.
Transfer to adult services. As shown in Supplementary
Table S3, during the study period 568 patients started RRT
in paediatric centres and transferred to an adult centre. Overall
82.1% started RRT in an adult renal unit, but this partially
reflects our choice of age groups to include in the analysis. Of
those 16–18 years of age, 176 (63%) started in an adult unit and
103 (37%) started in a paediatric unit. The median age of trans-
fer was 18 years.
Survival
Of the young adults who started RRT during the study
period, 283 (8.3%) died within 5 years. The median time to
death was 1.72 years (interquartile range 0.66–2.98).
Supplementary Figure S1 shows the Kaplan–Meier survival plot
by age group. Survival was worse with increasing age; the pro-
portion of patients that died was 3.3, 6.6, 9.0 and 11.1%,
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FIGURE 5: Start modality by age group in incident young adult RRT patients between 1999 and 2008. Percentages are shown for each group.
Some paediatric patients were known to have received dialysis at RRT start but the type was unknown.
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FIGURE 6: Overall modality proportions in the ﬁrst 5 years of RRT in surviving UK incident young adults. Percentages are shown for each
group. Some paediatric patients were known to have received dialysis at RRT start but the type was unknown.
U K y o u n g a d u l t s s t a r t i n g R R T — t h e f i r s t 5 y e a r s 5
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
||
respectively, for age groups 11–<16, 16–<21, 21–<26 and 26–
30 years (P< 0.0001). Mortality and survival data shown in
Table 2 demonstrate a higher crude mortality with older age
group but no linear trend in standardized mortality ratios
(SMR). The overall crude mortality was 18.0 (95% CI 16.0–20.
2) and the SMR was 45.1. The cumulative observed survival
decreased with older age group and was 0.91 overall. This was
hardly changed in the cumulative relative survival (improved by
0.003, or 3%). Therefore, survival was worse for older age
groups with or without adjustment for background general pop-
ulationmortality risk.
Table 3 displays a multivariable Cox regression model analy-
sing the influence of other variables in addition to age group on
the risk of death in incident young adults on RRT. Univariate
Cox regression (data shown in text only) showed a strong linear
effect of age group at RRT start on risk of death, with an HR of
2.33 (95% CI 1.25–4.34), 3.34 (1.85–6.01) and 4.02 (2.27–7.11),
respectively, for age groups 16–<21, 21–<26 and 26–30 com-
pared with 11–<16 (P< 0.0001). Adjusting for confounders
reduced the effect of age group. The strongest effect was seen
with modality; being on dialysis and not listed for transplant
drastically increased the risk of death compared with transplan-
tation [HR 17.6 (95% CI 4.36–70.9) P< 0.0001]. PRD had a
major effect on survival; compared with glomerulonephritis,
diabetics were nearly five times more likely to die [HR 4.48
(95% CI 3.05–6.58), P< 0.0001]. Other tubulointerstitial disor-
ders [HR 6.34 (95% CI 3.99–10.1), P< 0.0001], miscellaneous
renal conditions [HR 1.81 (95% CI 1.24–2.63), P¼ 0.002] and
other systemic diseases [HR 1.92 (95% CI 1.07–3.44), P¼ 0.03]
also increased the risk of death. Late presentation of ESRD
did not explain the findings, as excluding deaths in the first 90
days did not affect the HRs, and there were similar effects
between HD and PD, with low power due to reduced sample
size.
DISCUSSION
These new national UK results provide information on an
understudied population and show how the clinical epidemiol-
ogy, treatment and survival of young adults on RRT change
with age. We have created a unique resource linking two sepa-
rate datasets, bridging the gap between paediatric and adult
registries. Applying this approach to other disease registers
could yield similar comprehensive data for young adulthood.
Linkage was successful, with almost all paediatric cases being
traced into the adult database. Our long time period enabled us
to collate a relatively large population sample and gave us power
to test a variety of hypotheses.
We highlight several points: first, half the cohort started RRT
on HD, with about a third having started dialysis within 90 days
of the first nephrology review. Second, 1 in 10 young adults
were not listed for transplant by 5 years and were 20 times
more likely to die than those transplanted. Almost 1 in 10 young
adults died by 5 years from RRT start, a rate similar to that of
malignant melanoma [17]. We need to better understand the
reasons for these observations. Third, a diabetic PRD confers
additional risk with a 5-fold higher risk of death compared with
glomerulonephritis. Since 17% of 26–30 year olds had ESRD
due to diabetes, this is a key group for further research.
Our report would benefit from items we were unable to
report, including comorbidity (low completeness), reasons
patients were unfit for transplant and cause of death (missing in
46% of cases and coded as ‘Other’ in a further 18%). Future
work includes linking to ONS data to evaluate cause of death
and to report dialysis access and peritonitis rates, which may
add important context to the treatment modality trends. Our
dataset was not designed to evaluate longer-term graft loss, as
the transplant follow-up time was unequal, but we were able to
Table 1. Transplantation in the ﬁrst 5 years of RRT in incident UK young adults
11–< 16 years 16–< 21 years 21–< 26 years 26–30 years Total
Transplant status, n (%)
Transplanted in ﬁrst 5 years of RRT 480 (93.0) 568 (80.9) 669 (75.4) 913 (72.2) 2630 (78.0)
Listed and awaiting transplant 20 (3.9) 72 (10.3) 107 (12.1) 169 (13.4) 368 (10.9)
Not listed for transplant 16 (3.1) 62 (8.8) 111 (12.5) 183 (14.5) 372 (11.0)
Transplant timing*, n (%)
Pre-emptive 135 (28.1) 113 (19.9) 94 (14.1) 134 (14.7) 476 (18.1)
As second modality 277 (57.7) 342 (60.2) 435 (65.0) 591 (64.7) 1645 (62.5)
As third modality 52 (10.8) 91 (16.0) 106 (15.8) 149 (16.3) 398 (15.1)
 fourth modality 16 (3.3) 22 (3.9) 34 (5.1) 39 (4.3) 111 (4.2)
Transplant type, n (%)
DBD 317 (66.0) 257 (45.2) 286 (42.8) 428 (46.9) 1288 (49.0)
DCD 4 (0.8) 34 (6.0) 63 (9.4) 78 (8.5) 179 (6.8)
Live 159 (33.1) 276 (48.6) 315 (47.1) 398 (43.6) 1148 (43.7)
Missing 0 (0.0) 1 (0.2) 5 (0.8) 9 (1.0) 15 (0.6)
Time to cadaveric transplant from listing (median years)* 0.5 0.8 1.5 1.4
Transplant loss
1 year transplant failure, n (%) 38 (7.5) 40 (6.9) 46 (6.7) 50 (5.4) 174 (6.5)
Total number with 1-year follow-up 504 582 682 928 2696
DBD, donation after brain death; DCD, donation after circulatory death.
*P< 0.0001, chi-square test.
6 A.J. Hamilton et al.
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report the 1-year rate. Further, assessing the impact of social
deprivation using postcode data collected by the UKRR would
be valuable.
Our data have delineated how PRD distributions change
with age in young adults. The decrease in tubulointerstitial
diseases is likely due to the reduction in structural renal disor-
ders with advancing age, and we clearly see the emergence of
end-organ failure due to diabetes in the 26–30-year age group.
The proportion of ESRD due to diabetes in this age group
(17.4%) was very similar to that of UK adults in 2014 (16.1%)
Table 3. Cox regression model on the effect of age group at RRT start on mortality, adjusting age group by other variables
Variable Hazard ratio 95% CI P-value
Age group (years)
11–< 16 1.00
16–< 21 1.81 0.97–3.41 0.06
21–< 26 2.25 1.23–4.12 0.01
26–30 2.14 1.18–3.90 0.01
Sex
Male 1.00
Female 1.21 0.95–1.56 0.1
Ethnicity
White 1.00
Asian 0.67 0.42–1.08 0.1
Black 1.01 0.62–1.62 1.0
Other 0.94 0.46–1.92 0.9
Year of start
1999–2002 1.32 0.98–1.77 0.07
2003–05 0.97 0.71–1.33 0.9
2006–08 1.00
Modality
Transplant 1.00
Dialysis, transplant listed 4.12 0.92–18.4 0.06
Dialysis, not transplant listed 17.6 4.36–70.9 <0.0001
Primary renal diagnosis
Glomerular diseasea 1.00
Familial/hereditary nephropathies
Other familial/hereditary nephropathies 0.80 0.34–1.88 0.6
Polycystic kidney disease 1.07 0.33–3.43 0.9
Miscellaneous renal disorders 1.81 1.24–2.63 0.002
Systemic diseases affecting the kidney
Diabetesb 4.48 3.05–6.58 <0.0001
Other systemic diseasesc 1.92 1.07–3.44 0.03
Tubulointerstitial disease
Obstructive 1.77 1.01–3.09 0.05
Renal dysplasia6 reﬂux 0.46 0.21–1.01 0.05
Other tubulointerstitial diseased 6.34 3.99–10.1 <0.0001
Data based on 3243 patients and 259 events and excludes those with a missing ethnicity or PRD.
aGlomerular disease was chosen as a comparator, as it was the most frequent diagnosis.
bThere was a signiﬁcant non-proportionality over time between those with and without diabetes, with the effect seen only after 230 days and no effect on other HRs when using a piece-
wise Cox regression analysis; this model presents the overall HR for the entire follow-up period.
cPRD codes in the ‘other systemic diseases’ group include amyloid, haemolytic uraemic syndrome, renovascular diseases and hypertension. Of those with amyloid (n¼ 15), 33.3% died,
while the proportion of death from other conditions was 6.6, 8.6 and 6.5%, respectively.
dPRD codes in the ‘other tubulointerstitial disease’ group include drug-induced tubulopathies and interstitial nephritis; of those with drug-induced tubulopathies (n¼ 65), 32.3% died
and of those with interstitial nephritis (n¼ 45), 15.6% died.
Table 2. Mortality and survival by age group in incident young adult RRT patients compared with the general population
Crude mortality rate/1000 patient-years Standardized
mortality ratio
Cumulative survival
Young adult RRT
patients (95% CI)
Age-matched
general populationa
Observed survival in young
adult RRT patients
Relative survivalb (95%
CI)
Age group (years)
11–< 16 6.77 (2.90–15.8) 0.14 49.9 0.961 0.962 (0.938–0.978)
16–< 21 13.8 (10.3–18.4) 0.38 36.0 0.924 0.926 (0.901–0.946)
21–< 26 19.4 (10.1–37.3) 0.48 40.8 0.899 0.902 (0.877–0.921)
26–30 24.2 (13.0–45.1) 0.58 41.9 0.876 0.899 (0.857–0.898)
Overall 18.0 (16.0–20.2) 0.40 45.1 0.905 0.908 (0.896–0.918)
aUsing 2001–14 mortality data from the ONS, an equivalent period to the study follow-up (2000–13).
bCumulative relative survival accounts for the background risk of dying in the age-matched general population [14].
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|[2]. Miscellaneous renal disorders include unknown/uncertain
aetiology diagnoses, and the increase in these may reflect a
higher frequency of these with advancing age. Of this group,
56% were male, which may suggest the presence of undiagnosed
structural problems. Due to different PRD groupings, direct
comparison between UK paediatric and adult PRD data is
restricted; however, our results show the changing pattern from
predominant structural renal disease in childhood through to
increasing diabetes, hypertension and renovascular diseases in
late adulthood. The PRD data are consistent with previous evi-
dence in prevalent UK young adults 0–39 years of age [18]. UK
paediatric RRT data contribute 20% of European paediatric
registry data, suggesting the same patterns are likely to be seen
[19]. From an international perspective, the age, sex and PRD
ratios are comparable with a global cohort of young adult HD
patients 18–30 years of age [20].
Although pre-emptive transplant rates clearly decrease with
increasing age, the high proportion of unspecified dialysis in the
11–<16-year age group clouds comparison of trends in the use
of HD and PD at RRT start. Nevertheless, the use of PD at RRT
start was stable at30% across the older age groups. Compared
with adults in the UK in 2014, where 8.2% started RRT with a
transplant and 20.0% started on PD, pre-emptive transplanta-
tion and PD rates are higher in young adults [21], perhaps due
to PD being seen as more compatible with a young person’s life-
style. A higher proportion (29.3%) of cases was known to have
started dialysis within 90 days of the first nephrology review,
compared with 25.5% of children from 1996 to 2012 [22] and
18.0% of UK adults in 2014 [21]. However, this is based on lim-
ited ‘first seen date’ data (50% completeness). Assuming that an
anticipated RRT start would preferentially involve a transplant
or PD over HD would suggest high numbers of unexpected
starts in our dataset, with more than half the cases starting RRT
on HD. Our data in Figure 6 show PD is the least used modality
overall, and it would be helpful to better understand this.
The majority (81.9%) of young adults starting RRT experi-
enced dialysis prior to transplantation, which highlights the
need for appropriate dialysis preparation. The use of dona-
tion after circulatory death (DCD) kidney transplants
emerges during young adulthood. The source of donor kid-
neys used in transplantation was roughly equal between don-
ation after brainstem death (DBD) (49%) and living kidney
transplants (44%), with the remainder being DCD (7%) for
this group of young adult patients in the first 5 years of RRT.
This ratio is similar to that seen with prevalent UK children
in 2014 [1], but with increasing use of DCD kidneys in
young adults. In adults in 2012, the ratio of patients receiving
DBD (36%) and living kidney transplants (38%) was equal,
with a much higher use of DCD kidneys (26%) [23]. Those
in the two older age groups waited 11 months longer than
those in the youngest group for a deceased donor transplant,
reflecting UK allocation policy [3].
Almost 1 in 10 young adults had died by 5 years from RRT
start, with an inverse survival relationship with age. This may be
because the 26–30 year olds had the highest proportions of
dialysis use, not being transplanted by 5 years and diabetes. The
lower pre-emptive transplant rates and increased use of dialysis
in the older age groups may suggest a suboptimal pre-ESRD
period, and the cause of renal failure may explain barriers to
transplantation. This evidence would benefit from further
research, including psychosocial aspects. Other studies using
US registry data have shown an SMR of 35 for 10–15 year
olds and 15 for 16–21 year olds in the first year post-transplant
[24]. Our data in the first 5 years for all RRT showed SMRs of
50 and 36 for comparable age groups. Despite the wide CI, the
HR we present for those on dialysis and transplant listed (4.12)
is similar to that of previous studies in patients <21 years of
age receiving a first transplant (4.85) [25]. Compared with our
data, higher overall mortality of 38.6 per 1000 patient-years for
those 5–< 21 years of age has been reported [26], although this
study censored at transplantation and included younger chil-
dren who have poorer survival. Our relative survival analysis
showed that the cumulative observed survival and survival rela-
tive to the general population were broadly similar and indicate
that any excess death is likely to be renal related, taking into
account increasing mortality with age in the general population.
We found an increased risk of death for those with diabetes,
other tubulointerstitial disease, other systemic diseases and mis-
cellaneous renal disorders. The increased HR seen in the Cox
regression model confirms other European data where patients
with multisystem disorders and rare diseases had a significantly
higher risk of death compared with other groups [27]. The other
tubulointerstitial disease group HR result was influenced by
deaths in those with drug-induced tubulopathies, where a third
of cases died—possibly explained by malignancy and treatment
with platinum-based chemotherapy. The other systemic dis-
eases group result was similarly influenced by deaths in those
with amyloid, where again a third of cases died—perhaps
related to the disease itself or potentially toxic treatment regi-
mens. Survival of incident young adults starting RRT appears
worse than in children but better than in adults and older
adults, showing poorer survival with advancing age. Of our
cohort, 91.7% were alive at 5 years. Of children<16 years of age
starting RRT in the UK (2000–13), 6% died over 3.5-years
median follow-up [1]. In 2014, the unadjusted 5-year survival of
UK incident adult patients 18–64 years of age was 71.1%, and
32.9% for those65 years of age [28].
In summary, more than half the young adults in our cohort
started RRT on HD. In a Cox regression model, 1 in 10 young
adults were not listed for transplant by 5 years and were 20
times more likely to die than those who were transplanted.
Diabetes as a primary renal disease was common among young
adults and associated with increased mortality. Overall, almost
1 in 10 young adults had died by 5 years from the start of RRT.
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